A Charitable Evening Benefiting the National MS Society
Follow us on Instagram @mssolsticegala
The four of us, Dario Jiménez, Pierce Kennedy, Rex Ward, and Cooper Fallon, are roommates and longtime friends who wanted to build something beyond ourselves.
During our time at Santa Clara University, we organized events that collectively raised over $150,000 for the MS community. Those experiences shaped us. As we've settled into life in New York, the Manhattan Solstice Gala is our way of carrying that work forward.
On June 13, 2026, we're bringing together friends, family, and community for an evening of purpose at City Winery's Hudson Room.
Multiple sclerosis affects nearly one million Americans. Most are diagnosed between 20 and 50, in the middle of building their lives. It is unpredictable, often disabling, and without a cure. The National MS Society funds the research and programs that help people live better today while working toward a world free of MS tomorrow.
Every ticket to the Manhattan Solstice Gala goes directly toward that work — an elegant evening of open bar, bar snacks, and good company, with a specific purpose: to move the needle on one of medicine's most complex and underfunded challenges.
This event is currently sold out. Enter your information below and we'll be in touch if a spot opens up.
For waitlist inquiries, DM us on Instagram at @mssolsticegala or email us at manhattansolsticegala@gmail.com.
Donations made here support the event directly and are not tax-deductible. To make a tax-deductible contribution to the National MS Society, visit our team page: nationalmssociety.org ↗
Multiple sclerosis is a chronic disease of the central nervous system in which the immune system attacks the protective myelin sheath surrounding nerve fibers — disrupting the signals between the brain and the rest of the body.
The result can be anything from numbness and vision problems to paralysis and cognitive difficulty. MS is unpredictable. It affects each person differently. It can relapse and remit, or steadily progress. There is no known cure.
Most people are diagnosed between the ages of 20 and 50 — often in the prime of their personal and professional lives. The disease does not discriminate by background, profession, or aspiration. It simply arrives.